Skip to content

Alnylam Pharmaceuticals

US · ALNY #627 by market cap Listed 1970
143.82 -4.00 -2.71%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
B+
Momentum strategy signal
Strong Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Deteriorating
3
■ Upgrades■ Downgrades
  • 0 upgrades vs 3 downgrades among tracked analyst rating changes.
  • Most recent: Truist Financial moved from Buy to Hold on 2026-11-02.

Analyst consensus 25 analysts

Buy
Avg price target 317.34 +120.7%
Price target rangecurrent 143.82
Low199.00
Avg317.34
High455.00
Buy 76% Hold 24% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-06 Cantor Fitzgerald -- Hold 290.00
2026-11-06 H.C. Wainwright -- Buy 455.00
2026-11-05 Piper Sandler -- Buy 410.00
2026-11-05 BofA Securities -- Buy --
2026-11-05 BMO Capital -- Buy 292.00
2026-11-05 H.C. Wainwright -- Buy 455.00
2026-11-05 Oppenheimer -- Buy 320.00
2026-11-04 Wells Fargo -- Hold 220.00
2026-11-02 CCORF -- Buy 323.00
2026-11-02 Truist Financial -- Hold 225.00
2026-11-02 Barclays -- Buy 380.00
2026-10-30 Chardan Capital -- Buy 375.00
2026-10-30 Bernstein -- Hold 199.00
2026-10-30 UBS -- Buy 329.00
2026-10-30 Piper Sandler -- Buy 410.00
2026-10-30 Raymond James -- Buy 315.00
2026-10-30 Freedom Capital Markets -- Buy 350.00
2026-10-30 Morgan Stanley -- Hold 240.00
2026-10-30 Goldman Sachs -- Buy 320.00
2026-10-30 H.C. Wainwright -- Buy 455.00
2026-10-30 Barclays -- Buy 450.00
2026-10-29 TD Cowen -- Buy 354.00
2026-10-29 BofA Securities -- Buy 287.00
2026-10-29 Jefferies -- Hold 250.00
2026-10-29 H.C. Wainwright -- Buy 455.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-11-02 Truist Financial Buy → Hold 225.00
2026-10-30 Bernstein Buy → Hold 199.00
2026-03-15 Jefferies Buy → Hold 330.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-10-29 -- ±11.20% -25.13% (beat)
2026/Q2 2026-07-30 -- ±10.10% -28.31% (beat)
2026/Q1 2026-04-30 -- ±7.83% +2.76% (in line)
2025/Q4 2026-02-12 -- ±6.44% -4.28% (in line)
2025/Q3 2025-10-30 -- ±10.17% -6.65% (in line)
2025/Q2 2025-07-31 -- ±8.25% +15.43% (beat)
2025/Q1 2025-05-01 -- ±9.13% -3.08% (in line)
2024/Q4 2025-02-13 -- ±7.08% -0.40% (in line)
2024/Q3 2024-10-31 -- ±8.42% -5.29% (in line)
2024/Q2 2024-08-01 -- ±7.79% +13.12% (beat)
2024/Q1 2024-05-02 -- ±8.84% +0.23% (in line)
2023/Q4 2024-02-15 -- ±5.44% -10.19% (beat)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Alnylam Pharmaceuticals discussion 0 comments

Add a comment